(Reuters) - A Merck & Co drug that helps the immune system fight cancer was about twice as effective as the current standard therapy for patients with recurrent or advanced head and neck cancers, according to study data released on Friday.
DRESDEN, Germany (Reuters) - The United States warned on Friday of a possible accident for the world economy if Greece and its creditors miss their June deadlines to avert a debt default.
Entrepreneurs and investors are always trying to predict what the “next big thing” will be. More often than not, the same buzzwords appear time and time again. From “big data” to the “Uber of (name your noun)” — the next big thing always seems to be a derivation of whatever
It's not just hotshot personalities and luminaries like Evan Spiegel, Blake Lively, Malala Yousafzai and Sean Rad who make up the FORBES 30 Under 30 list. They are also your college roommates, colleagues, childhood friends and even people you don't know personally but admire their work. You may be a
Chicago (Reuters) - Bristol-Myers Squibb Co's drug, Opdivo, improved survival for patients with the most common form of lung cancer, nearly doubling survival for those with high levels of a specific protein in their tumors compared with chemotherapy, according to clinical trial results presented on Friday.
CHICAGO (Reuters) - Patients with colon and other cancers who have a specific defect in genes needed for DNA repair are far more likely to respond to a new class of drugs such as Merck & Co's Keytruda, which enlist the immune system to attack tumors, a new study has
BOGOTA (Thomson Reuters Foundation) - The number of Haitians infected by cholera has risen more than 300 percent in the past year as early rains, poor sanitation, and a lack of funding means the impoverished Caribbean nation struggles to stem the disease, the United Nations said.
(Reuters) - The World Health Organization is set to examine a widely used pesticide and agribusiness is bracing for bad news, less than three months after the group classified another popular herbicide as "probably" cancer-causing.
MILAN (Reuters) - Britain's Vodafone and Vimpelcom's Italian mobile phone unit Wind have signed a letter of intent with shareholders of broadband firm Metroweb to build a fiber optic network in Italy, the companies said in a joint statement.